Catalyst
Slingshot members are tracking this event:
Phase I study initiated for durvalumab in combination with monalizumab in patients with solid tumors
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IPHYF |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 08, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Durvalumab, Monalizumab
